Fulcrum Therapeutics, Inc.
NASDAQ:FULC
3.53 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 58.212 | 25.563 | 35.098 | 35.412 | 57.052 | 96.713 | 72.797 | 0.407 |
| Short Term Investments
| 182.809 | 210.658 | 167.823 | 182.75 | 55.862 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 241.021 | 236.221 | 202.921 | 218.162 | 112.914 | 96.713 | 72.797 | 0.407 |
| Net Receivables
| 3.342 | 2.249 | 1.081 | 4.11 | 2.707 | 0.111 | 0.501 | 0.039 |
| Inventory
| 0 | 0 | -0.852 | -0.473 | -2.781 | 2.975 | 0.559 | 0.734 |
| Other Current Assets
| 5.56 | 3.729 | 3.517 | 3.726 | 3.889 | 3.259 | 0.797 | 0.892 |
| Total Current Assets
| 249.923 | 242.199 | 207.519 | 225.998 | 112.914 | 100.083 | 74.095 | 1.338 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 9.584 | 12.392 | 15.969 | 7.368 | 8.397 | 87.943 | 10.546 | 2.942 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.092 | 1.092 | 1.092 | 1.092 | 1.092 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.211 | 3.103 | 2.105 | 0.542 | 7.174 | -78.679 | 0.038 | 0.06 |
| Total Non-Current Assets
| 10.795 | 15.495 | 19.166 | 9.002 | 16.663 | 10.356 | 11.676 | 3.002 |
| Total Assets
| 260.718 | 257.694 | 226.685 | 235 | 129.577 | 110.439 | 85.771 | 4.34 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 1.164 | 2.757 | 3.638 | 4.788 | 4.079 | 2.186 | 1.263 | 1.673 |
| Short Term Debt
| 2.186 | 2.192 | 5.204 | 0 | 0.017 | 0.05 | 0.046 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0.934 | 4.711 | 14.91 | 3.989 | 2.8 | 0 |
| Other Current Liabilities
| 7.694 | 8.726 | 6.949 | 9.7 | 7.719 | 5.915 | 2.92 | 1.112 |
| Total Current Liabilities
| 11.044 | 13.675 | 16.725 | 19.199 | 26.725 | 12.14 | 4.229 | 2.785 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 6.443 | 8.629 | 10.821 | 0 | 0 | 0 | 0 | 34.587 |
| Deferred Revenue Non-Current
| 0 | 0 | 0.197 | 0 | 2.971 | 6.011 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -0.197 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.197 | 0.197 | 0.197 | 4.262 | 4.7 | 5.135 | 5.542 | -34.354 |
| Total Non-Current Liabilities
| 6.64 | 8.826 | 11.018 | 4.262 | 7.671 | 11.146 | 5.542 | 0.233 |
| Total Liabilities
| 17.684 | 22.501 | 27.743 | 23.461 | 34.396 | 23.286 | 9.771 | 3.018 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 110.439 | 139.67 | 34.587 |
| Common Stock
| 0.054 | 0.062 | 0.052 | 0.041 | 0.028 | 0.023 | 0.016 | 0.001 |
| Retained Earnings
| -519.398 | -509.673 | -412.338 | -302.467 | -221.62 | -150.801 | -68.124 | -35.536 |
| Accumulated Other Comprehensive Income/Loss
| 0.13 | -0.136 | -0.797 | -0.397 | -0.002 | -110.439 | -1.958 | -0.893 |
| Other Total Stockholders Equity
| 762.248 | 744.94 | 612.025 | 514.362 | 316.775 | 237.931 | 6.41 | 2.27 |
| Total Shareholders Equity
| 243.034 | 235.193 | 198.942 | 211.539 | 95.181 | 87.153 | 76 | 1.322 |
| Total Equity
| 243.034 | 235.193 | 198.942 | 211.539 | 95.181 | 87.153 | 76 | 1.322 |
| Total Liabilities & Shareholders Equity
| 260.718 | 257.694 | 226.685 | 235 | 129.577 | 110.439 | 85.771 | 4.34 |